1. Immune function in cigarette smokers who quit smoking for 31 days
Charles J. Meliska, PhDa, Mary E. Stunkard, PhDb, David G. Gilbert, PhDc, Robert A. Jensen, PhDc, John M. Martinko, PhDb 
Journal of Allergy and Clinical Immunology 
Volume 95, Issue 4, Pages (April 1995)
DOI: /S (95)
Copyright © 1995 Mosby, Inc. Terms and Conditions

2. FIG. 1
Mean plasma nicotine (A) and cotinine (B) concentrations in Quitters (n = 28) and Smokers (n = 11) on two baseline days ( B1 and B2) and on test days across 31 days during the smoking abstinence phase (C1 to C31). Vertical lines indicate standard errors.
Journal of Allergy and Clinical Immunology  , DOI: ( /S (95) )
Copyright © 1995 Mosby, Inc. Terms and Conditions

3. FIG. 1
Mean plasma nicotine (A) and cotinine (B) concentrations in Quitters (n = 28) and Smokers (n = 11) on two baseline days ( B1 and B2) and on test days across 31 days during the smoking abstinence phase (C1 to C31). Vertical lines indicate standard errors.
Journal of Allergy and Clinical Immunology  , DOI: ( /S (95) )
Copyright © 1995 Mosby, Inc. Terms and Conditions

4. FIG. 2
Mean changes in NKCA (percent lysis) in Quitters (n = 28) and Smokers (n = 11) across 31 days of testing, at four E:T ratios. Vertical lines represent standard errors. Asterisks refer to significance of differences between Quitters and Smokers. *p < 0.05; **p < Letters refer to significance of differences from baseline a p < 0.05; bp < 0.08.
Journal of Allergy and Clinical Immunology  , DOI: ( /S (95) )
Copyright © 1995 Mosby, Inc. Terms and Conditions